Home > Result Summaries: Compounds > GSK598809 Result Summaries: GSK598809 GSKStudy ID Phase Title Summary (Download) 109710 phase 1 A single-blind, randomized, placebo controlled, two-period crossover fMRI study to investigate the effects of the D3 antagonist GSK598809 on neural and behavioural responses to food reward and reinforcement after a single oral dose of GSK598809 in overweight and obese subjects. (1 citation(s)) DAN106593 phase 1 A randomized, double-bind, placebo controlled, two-way cross-over study to assess the effects of a single dose of GSK598809, a Selective DRD3 Antagonist, in Modulating Nicotine Reward (1 citation(s))
